In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.

Many organizations hope to improve operations using a cycle of fragmented, standalone, short-term improvements. While a great deal of effort is expended, it often isn’t enough to move the needle.